National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Aspirin and Cancer Prevention
    Posted: 12/07/2005
Related Pages
Search for Clinical Trials 1
NCI's PDQ® Cancer Clinical Trials Registry.

Cyclooxygenase (COX) Inhibitors 2
A collection of material about cyclooxygenase (COX) inhibitors - drugs that are being tested for a variety of therapeutic purposes, including the prevention and treatment of certain cancers.

Cancer Prevention 3
Cancer prevention information from the National Cancer Institute, including prevention information for specific cancers.
Closed Clinical Trials

Current knowledge about aspirin's potential role in cancer prevention comes from a range of clinical trials that are now completed and closed to enrollment. The following link provides a list of such trials drawn from PDQ®, the clinical trials database of the National Cancer Institute.

The list includes not only prevention trials, but also studies of what affect aspirin might have on such cancer-related issues as blood clotting and pain. Findings from these trials may or may not have been published in the medical literature. Aspirin's chemical name is acetylsalicyclic acid.

Closed clinical trials involving aspirin 4



Table of Links

1http://www.cancer.gov/clinicaltrials/search
2http://www.cancer.gov/cancertopics/COX-inhibitors
3http://www.cancer.gov/cancertopics/prevention-genetics-causes/prevention
4http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39152&idtype=1&closed=1